Kentucky's medical marijuana program has opened just 39 dispensaries across the state, leaving thousands of registered patients scrambling to access products nearly 20 months after the legislature approved the program in 2023.
The slow rollout represents one of the most constrained medical cannabis launches in recent years. State regulators have struggled to process cultivation and processor licenses quickly enough to meet patient demand, creating supply chain bottlenecks that industry observers say could have been avoided with more aggressive pre-launch planning.
"We're seeing patients drive two or three hours to find product in stock," said Sarah Mitchell, executive director of the Kentucky Cannabis Association. "The state set up a system that requires multiple license types, but they didn't issue them in a coordinated way."
Kentucky's program requires separate licenses for cultivation, processing, and retail operations. While the state has issued retail licenses at a relatively steady pace, cultivation licenses have lagged significantly. Without enough growers to supply processors, and processors to supply dispensaries, the entire supply chain has bottlenecked.
The Numbers
As of this month, Kentucky has issued approximately 15,000 medical marijuana cards to patients with qualifying conditions. But with just 39 dispensaries operational statewide, that translates to roughly 385 patients per dispensary. By comparison, neighboring Illinois had over 50 medical dispensaries serving a similar patient population before adult-use legalization in 2020.
The state's Office of Medical Cannabis has approved 89 dispensary licenses total, meaning more than half of licensed retailers have yet to open their doors. Industry sources cite construction delays, local zoning disputes, and difficulty securing banking relationships as common obstacles.
Cultivation capacity presents an even starker picture. Kentucky has licensed fewer than a dozen cultivation facilities, and only a handful have begun harvesting product. The state's tiered licensing system allows for micro-cultivators, standard cultivators, and large-scale operations, but even the largest licensed growers are months away from reaching full production capacity.
Licensing Delays
The Kentucky Office of Medical Cannabis has faced criticism for what some applicants describe as an opaque and slow-moving review process. Several cultivation applicants report waiting six months or longer for final approval after submitting complete applications.
"Other states have shown you can do this faster without compromising oversight," Mitchell said. "Missouri got its medical program up and running in about 18 months from passage to patient sales. We're nearly at 20 months and still don't have adequate supply."
State officials have defended the timeline, noting that Kentucky's program includes robust compliance requirements and local input provisions that other states lacked at launch. The office did not respond to requests for comment on specific licensing timelines.
Some industry veterans see Kentucky's struggles as a cautionary tale for other emerging markets. Maryland faced similar supply constraints when it launched medical sales in 2017, leading to product shortages that took nearly a year to resolve. Virginia's more recent rollout avoided those pitfalls by issuing cultivation licenses months before retail licenses.
What's Next
The Kentucky Cannabis Association projects that supply will begin to stabilize by mid-2025 as more cultivation facilities come online and reach harvest cycles. But that timeline depends on the state processing pending licenses without further delays.
Meanwhile, patient advocates have pushed lawmakers to expand the list of qualifying conditions and increase the number of available licenses. A bill introduced in the current legislative session would allow nurse practitioners to certify patients, potentially doubling the number of medical professionals who can recommend cannabis.
For now, Kentucky's medical marijuana patients continue to face limited options and frequent stockouts. Several advocacy groups have called on state regulators to implement an emergency expedited review process for cultivation licenses to address the supply shortage.
The state's next quarterly licensing update is expected in March.
This article is based on original reporting by mjbizdaily.com.
